Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Blood Advances
|
March 31, 2021
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
L Alexander Liggett, Matthew D Galbraith, Keith P Smith, et al.
Elife
|
May 29, 2014
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
Mary Ann Allen, Zdenek Andrysik, Veronica L Dengler, et al.
Mbio
|
January 26, 2026
The Dp16 Down syndrome mouse model does not exhibit oral interferon-gammopathy or susceptibility to oral candidiasis
Ashira Lubkin, Ramon A Lujan, Sergio M Pontejo, et al.
Cell Reports
|
March 10, 2023
FAM193A is a positive regulator of p53 activity
Maria M Szwarc, Anna L Guarnieri, Molishree Joshi, et al.
Elife
|
July 30, 2016
Trisomy 21 consistently activates the interferon response
Kelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
Molecular Cancer Therapeutics
|
March 12, 2015
p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
John J Tentler, Anastasia A Ionkina, Aik Choon Tan, et al.
Cell Reports
|
January 15, 2026
Altered hepatic metabolism in Down syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Altered Hepatic Metabolism in Down Syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Iscience
|
August 9, 2023
Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection
Samantha N Thomas, Brian F Niemeyer, Rocio J Jimenez-Valdes, et al.
Frontiers in Immunology
|
June 8, 2026
Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome
Janelle N Posey, Mariah Jordan, Amanda Olsen-Dufour, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Blood Advances
|
March 31, 2021
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
L Alexander Liggett, Matthew D Galbraith, Keith P Smith, et al.
Elife
|
May 29, 2014
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
Mary Ann Allen, Zdenek Andrysik, Veronica L Dengler, et al.
Mbio
|
January 26, 2026
The Dp16 Down syndrome mouse model does not exhibit oral interferon-gammopathy or susceptibility to oral candidiasis
Ashira Lubkin, Ramon A Lujan, Sergio M Pontejo, et al.
Cell Reports
|
March 10, 2023
FAM193A is a positive regulator of p53 activity
Maria M Szwarc, Anna L Guarnieri, Molishree Joshi, et al.
Elife
|
July 30, 2016
Trisomy 21 consistently activates the interferon response
Kelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
Molecular Cancer Therapeutics
|
March 12, 2015
p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
John J Tentler, Anastasia A Ionkina, Aik Choon Tan, et al.
Cell Reports
|
January 15, 2026
Altered hepatic metabolism in Down syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Altered Hepatic Metabolism in Down Syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Iscience
|
August 9, 2023
Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection
Samantha N Thomas, Brian F Niemeyer, Rocio J Jimenez-Valdes, et al.
Frontiers in Immunology
|
June 8, 2026
Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome
Janelle N Posey, Mariah Jordan, Amanda Olsen-Dufour, et al.
Page
of 7